I've been following Microba since IPO and believe the current share price close to cash backing is offering value and a margin of safety.
There are three parts of the business: services, clinical pipeline and data. The upcoming quarterly will give an early indication if their services momentum in filtering through to revenue.
Data however is the key that will drive down pipeline discovery costs and eventually make this an acquisition target.
The gut is the 'second brain'.
- Forums
- ASX - By Stock
- Ann: Investor Presentation October 2022
MAP
microba life sciences limited
Add to My Watchlist
4.17%
!
9.2¢

I've been following Microba since IPO and believe the current...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
-0.004(4.17%) |
Mkt cap ! $47.38M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.2¢ | $11.09K | 118.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 20774 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 114482 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 20774 | 0.092 |
4 | 60967 | 0.091 |
7 | 405677 | 0.090 |
2 | 192844 | 0.089 |
2 | 12552 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 114482 | 1 |
0.099 | 88000 | 1 |
0.100 | 100000 | 1 |
0.105 | 103000 | 1 |
0.110 | 1714 | 1 |
Last trade - 15.11pm 29/07/2025 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |